Borrowing from the cancer playbook to find treatment for Alzheimer's disease

It's been notoriously difficult to develop medicines for Alzheimer's disease, the sixth leading cause of death in the United States. Each year, it seems, pharmaceutical companies release data from studies of promising drug candidates that merit only a collective sigh of disappointment.

In search of fresh ideas, researchers have begun to borrow a phrase or two from the more familiar language of cancer treatment.

Some scientists are studying precision medicine, or personalized medicine, which is routinely used to treat breast and colon cancers. Other researchers are focusing on immunotherapy, an effective form of medicine for skin, lung, kidney, bladder and other cancers.

This translation of the cancer-fighting vocabulary to Alzheimer's disease, though, is not always simple.

To read the full article, click HERE